Teva Pharmaceutical Industries Limited

(NASDAQ:TEVA)
  Jun 30, 2008 Mar 31, 2008 Dec 31, 2007 Sep 30, 2007
Cash Flow Statement
Cash At Beginning Of Period 1,488,000 1,488,000 1,332,000 1,332,000
Cash At End Of Period 2,484,000 2,509,000 1,488,000 1,508,000
Net Change In Cash And Cash Equivalents 996,000 1,021,000 156,000 176,000
Effect Of Exchange Rate Changes 92,000 48,000 58,000 37,000
Net Income Or Loss 686,000 147,000 1,952,000 1,382,000
Cash From Operating Activities
Depreciation Expenses 248,000 126,000 521,000 381,000
Amortization Expenses — — — —
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes -153,000 -39,000 111,000 24,000
Operating Gains Or Losses 46,000 406,000 16,000 18,000
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables 467,000 217,000 -316,000 -185,000
Increase Or Decrease In Inventories -348,000 -118,000 -421,000 -316,000
Increase Or Decrease In Prepaid Expenses — — — —
Increase Or Decrease In Other Current Assets — — — —
Increase Or Decrease In Payables — — — —
Increase Or Decrease In Other Current Liabilities 113,000 -57,000 -117,000 -87,000
Increase Or Decrease In Other Working Capital — — — —
Other Non Cash Items — — — —
Net Cash From Continuing Operations 493,000 64,000 67,000 51,000
Net Cash From Discontinued Operations 1,552,000 746,000 1,813,000 1,268,000
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments 1,890,000 1,356,000 4,520,000 3,661,000
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -322,000 -142,000 -542,000 -394,000
Acquisitions -414,000 -410,000 -18,000 -17,000
Purchase Of Long Term Investments — -716,000 -5,298,000 -4,159,000
Purchase Of Short Term Investments -1,353,000 — — —
Other Investing Changes Net 72,000 27,000 -15,000 -14,000
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities -127,000 115,000 -1,353,000 -923,000
Cash From Financing Activities
Issuance Of Debt 45,000 36,000 212,000 167,000
Issuance Of Capital Stock -380,000 -3,000 -195,000 -66,000
Repayment Of Debt — — -152,000 -152,000
Repurchase Of Capital Stock -201,000 -95,000 -299,000 -220,000
Payment Of Cash Dividends 12,000 9,000 35,000 52,000
Net Other Financing Charges 12,000 9,000 35,000 52,000
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities -521,000 112,000 -362,000 -206,000